Redefining Partnerships.

Senator Bill Frist is a leading authority on healthcare and former U.S. Senate Majority Leader. As Co-founder and Partner at FCV, he resides on the fund’s Investment Committee and is responsible for acquisition, divestitures and providing unique value to the fund’s partnerships.

Senator Frist served two terms as a United States Senator representing Tennessee, serving as Majority Leader from 2003 until his retirement in 2007. His leadership was instrumental in the passage of the 2003 Medicare Modernization Act and the historic PEPFAR legislation that provided life-saving treatment globally to over 20 million people. Prior to the Senate, he founded the Vanderbilt Multi-Organ Transplant Center and has performed more than 150 heart and lung transplant procedures. His current board service includes Select Medical (NYSE: SEM), AECOM (NYSE: ACM), Teladoc (NYSE: TDOC), Aegis Sciences, Accolade, Devoted Health, OneOncology, Kaiser Family Foundation, Robert Wood Johnson Foundation, The Nature Conservancy, the Harvard Medical School Board of Fellows and the Smithsonian National Museum of the American Indian.

Senator Frist received his M.D. from Harvard Medical School and holds a B.A. from Princeton University.

Bryan Cressey is a pioneer in the field of private equity investing and co-founder of three of the largest private equity firms in the US. He has managed billions of dollars of private capital, spent his career investing in healthcare, is a co-founder of FCV and serves as a Senior Advisor to the firm.

He is an acknowledged expert in healthcare, where he has invested over 30 years, and his firms are well known for their consistently strong investment returns. He has been featured in Time Magazine and Fortune Magazine and is asked to speak nationwide on healthcare and private equity investing. He served as Chairman of an NYSE company, Belden, and is a Director of several others, and has been elected to Chicago’s Entrepreneurial Hall of Fame and Chicago’s Business Hall of Fame. Bryan recently created an addiction treatment center called Above and Beyond, on Chicago’s Westside, providing life transformation opportunities, free to the homeless and poor.

He holds a J.D. from Harvard Law School, an M.B.A. from Harvard Business School and a B.A. in Economics from the University of Washington, Phi Beta Kappa.

Chris is partner with Frist Cressey Ventures. Prior to joining FCV in 2016, Mr. Booker invested and/or served on the board of leading enterprises such as ProviderTrust, NContracts, Criterion Holdings Corporation, Woodland Street Partners, Stratasan and Paragon Group. Prior to joining FCV, he worked at XMi Holdings, first as a partner and then as president of XMi Capital, where he participated in over 50 transactions. While at XMi Holdings, he was CFO and served as a director to healthcare services firm Criterion Holdings Corporation, which grew from 3 to nearly 600 employees before being acquired in 2016.

In addition to his responsibilities at FCV, he is an active board member of nonprofit organizations in the Nashville area as well as Monogram Health and ObjectiveHealth. Chris is a graduate of Vanderbilt University with a B.S. in Engineering and Economics.

Navid is a partner with Frist Cressey Ventures. Prior to joining FCV in 2019, he worked with Morgan Noble, an investment firm that focuses exclusively on companies determined to change the future of healthcare. Before Morgan Noble, he was with Enhanced Equity Funds, a healthcare-focused private equity firm based in New York, and has also previously held positions with Lehman Brothers’ healthcare investment banking division, Ernst & Young’s Transaction Advisory group and Arthur Andersen’s healthcare practice.

Navid has also served as the Chief Strategy Officer of Continuum Health, a physician enablement company providing practice management and population health services to medical groups. He has been an investor and/or served on the board of directors of Mindoula Health, Continuum Health, Captify Health, Privia Health and Trusted Health Plans.

He holds an MBA from the NYU Stern School of Business and a Bachelor of Arts from Loyola University.

Olivia Capra joined FCV in 2022 as Principal. Prior to FCV, Olivia was an investor at Kaiser Permanente Ventures and Convey Capital, and was active on the boards of Ginger [now Headspace Health], Everytable, Intelycare and Protenus. Previously, Olivia led early commercial operations and growth strategy for Macro Trials and Cornerstone AI, two healthcare technology companies in the Initiate Venture Studio portfolio. Olivia started her career as an Equity Research Analyst at Barclays covering the specialty pharmaceutical sector for six years. She is a Co-Founder of The Grind, a national organization for women & nonbinary founders, operators, and investors in healthcare innovation.

Olivia graduated from the London School of Economics with a BSc Honors in Economics and Social Policy. She is a Chartered Financial Analyst (CFA).

Caroline Young joined as Vice President of Partnership Development with Frist Cressey Ventures in 2021. Ms. Young focuses on accelerating value for FCV’s partnerships and enhancing relationships with our industry-wide stakeholders.

Prior to FCV, Ms. Young partnered with Former U.S. Senate Majority Leader Bill Frist to launch NashvilleHealth, a first-of-a-kind initiative to reduce disparities and drive community-level health improvement. Prior to that role, Caroline led one of the nation’s premier health care industry associations, the Nashville Health Care Council, where she cultivated a national network of executives in support of industry leadership and innovation.

Ms. Young currently serves on the board of Hint Health and Cumberland Pharmaceuticals (NASDAQ: CPIX). She is also a member of the Advisory Board of the Washington, DC-based Women Business Leaders of the U.S. Healthcare Industry.

Ms. Young holds an MS from the University of Tennessee and a BA from the University of Mississippi.

Zach Johnson joined Frist Cressey Ventures in 2021 and is involved with accounting and financial reporting as well as compliance and administrative operations. Prior to joining Frist Cressey Ventures, Mr. Johnson worked as a tax manager with RSM US LLP in their Chicago and Nashville offices, specializing in tax consulting and compliance for funds holding a variety of assets.

Mr. Johnson graduated from Marquette University with a B.S. in Accounting and Finance. Mr. Johnson is a Certified Public Accountant holding an active license in Tennessee. He is a member of the American Institute of Certified Public Accountants and the Tennessee Society of CPAs.

CONTACT Zach Johnson

Matt Schappell joined Frist Cressey Ventures in 2019 and is involved with investment origination and execution as well as post-close value creation for the Firm’s partnerships. Prior to FCV, Mr. Schappell worked in Investment Banking for the Healthcare Technology Group at Ziegler in Chicago. Before Ziegler, he held a Business Development position at a subsidiary hospital of Universal Health Services (UHS).

Mr. Schappell graduated from Wheaton College (IL) with a B.A. in Business and Economics and a concentration in Applied Health Sciences.

CONTACT Matt Schappell

Katie Hock joined Frist Cressey Ventures in 2019. Prior to FCV, Ms. Hock led and supported Marketing & Communications initiatives at various organizations as the Marketing Project Manager, Senior Marketing Manager and Director of Communications and Member Services. She also supported the executives and sales team at CoreTrust Purchasing Group in managing and growing their Private Equity line of business.

Ms. Hock holds an MBA and a B.S. in Business with a minor in Marketing from Cumberland University.

CONTACT Katie Hock

Derek Dedeker joined Frist Cressey Ventures in 2022 and is involved with investment origination and execution as well as post-close value creation for the Firm’s partnerships. Prior to FCV, Mr. Dedeker spent 4 years at Santé Ventures, an early-stage healthcare venture capital firm based in Austin. Prior to Santé, he worked as an Investment Banking Senior Analyst in the Financial Institutions Group at Citi in New York City, where he worked on a variety of M&A and equity transactions.

Mr. Dedeker graduated from Texas Christian University (TCU) with a B.B.A. in Finance.

CONTACT Derek Dedeker

Lauren Ingram joined Frist Cressey Ventures in 2021 and is involved with the Partnership Development Team. Prior to FCV, Lauren completed her Master of Arts in the department of Medicine, Health, and Society at Vanderbilt University.

Ms. Ingram graduated from Princeton University with a B.A. in Cultural Anthropology and certificates in Global Health and American Studies. Before returning to pursue her MA, she worked as a Director of Sales and Solutions Consulting at Quid Inc., a data analytics and natural language processing company in San Francisco.

CONTACT Lauren Elcan

William Trapnell joined Frist Cressey Ventures in 2021 and is involved with investment origination and execution as well as post-close value creation for the Firm’s partnerships. Prior to FCV, Mr. Trapnell worked as an Investment Banking Senior Analyst in the Healthcare Group at Citi in New York City, where he worked on a variety of M&A and equity transactions.

Mr. Trapnell graduated from the University of Tennessee with a B.S. in Accounting with a concentration in International Business.

CONTACT WILLIAM TRAPNELL

Traci Few joined Frist Cressey Ventures in 2021 and provides executive support to the Firm and Partners. Prior to FCV, Traci supported key executives in the healthcare, commercial real estate and legal industries, most recently with HCA and Parallon. She additionally managed and marketed charitable campaigns for the organizations.

A native Nashvillian, she attended Lipscomb University.

CONTACT Traci Few